A landmark Lancet study reveals that HPV vaccination has driven cervical cancer deaths in young English women to virtually zero — but the gains are now at risk.
Here is a number worth pausing on. Between 2020 and 2024, not a single woman aged 20 to 24 died of cervical cancer in England. Not one. For context, roughly 3,300 women in England are still diagnosed with the disease every year, and cervical cancer remains the fourth most common cancer in women worldwide, according to the World Health Organization.
Yet for one entire age group, the death toll has been erased — and researchers think they know exactly why. The credit goes to a jab that has been offered to schoolchildren in England since 2008. A new analysis led by Professor Peter Sasieni of Queen Mary University of London, funded by Cancer Research UK and published in The Lancet, is the first study to measure not just whether the HPV vaccine prevents cancer, but whether it actually prevents death. The answer is striking.
Girls who were vaccinated at age 12 or 13 now face an almost zero probability of dying from cervical cancer before the age of 30.